Rad51 supports triple negative breast cancer metastasis.

Overview of attention for article published in Oncotarget, April 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 80 Dimensions

Readers on

mendeley: 65 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Compounds for selective disruption of protein-protein interactions

Grant US-11780881-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.